NIH-funded research R01 grant

Pharmacy-based PrEP to help women stay on HIV prevention in Zimbabwe

Official title: A randomized trial to determine impact, cost and cost effectiveness of pharmacy-based PrEP on PrEP continuation for women at high risk of HIV

Funded at Centre/sexual Hlth/hiv Aid Res/zimbabwe · NIH-11391666 · Data updated 2026-11-12

A new, patient-friendly trial tests whether letting women get PrEP refills from local pharmacies helps them stay on prevention more reliably and cost-effectively.

More PrEP research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionCentre/sexual Hlth/hiv Aid Res/zimbabwe
NIH-funded
Lab location1 site (Harare, Zimbabwe)
Project startSeptember 3, 2026
Project endMay 31, 2031
Funding year2026
Award (this year)$42,639
NIH project number3R01MH140751-01S2
Project IDNIH-11391666 on NIH RePORTER

Who could benefit from this research

Could help

Women at high risk of HIV in Zimbabwe who are starting PrEP and are willing to use either pharmacy-based or clinic-based refills.

Less likely to help

Women who are unlikely to use medications regularly or who prefer clinic-only services may see limited benefit.

What this research studies

This project builds on a successful pilot in Harare that showed good acceptability when PrEP refills could be picked up at community pharmacies. The trial will compare standard clinic-based refills with pharmacy-based refills, looking at how often participants continue PrEP over time and the costs involved. It will involve women at high risk of HIV, following them through pharmacy or clinic refill options and collecting data on adherence, barriers, and overall use. The study is embedded in Zimbabwe’s national KP program and aims to inform scalable strategies to keep women protected.

Why it matters

Potential benefit: If successful, the approach could make PrEP more accessible and affordable for women at risk, leading to higher continuation and better protection.

How similar studies have gone: Preliminary pilot results indicated high acceptability and potential effectiveness of pharmacy-based PrEP refills, warranting a larger trial.

Where this research is happening

  • Centre/sexual Hlth/hiv Aid Res/zimbabwe
    Harare, Zimbabwe
    Active

Researchers

  • Principal investigator: Sibanda, Euphemia Lindelwe — Centre/sexual Hlth/hiv Aid Res/zimbabwe
  • Study coordinator: Sibanda, Euphemia Lindelwe

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.